Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OCUL Ocular Therapeutix > Detailed Quotes

OCUL Ocular Therapeutix

4.150
-0.980-19.10%
Close 09/30 16:00 ET
4.190
+0.040+0.96%
Post Mkt Price 09/30 19:58 ET
High
5.280
Open
5.060
Turnover
14.50M
Low
4.150
Pre Close
5.130
Volume
3.18M
Market Cap
319.41M
P/E(TTM)
Loss
52wk High
12.500
Shares
76.97M
P/E(Static)
Loss
52wk Low
2.910
Float Cap
292.96M
Bid/Ask %
20.00%
Historical High
44.190
Shs Float
70.59M
Volume Ratio
1.25
Historical Low
2.350
Dividend TTM
--
Div Yield TTM
--
P/B
4.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
4.50%
Amplitude
22.03%
Avg Price
4.561
Lot Size
1
Float Cap
292.96M
Bid/Ask %
20.00%
Historical High
44.190
Shs Float
70.59M
Volume Ratio
1.25
Historical Low
2.350
Dividend TTM
--
P/B
4.85
Dividend LFY
--
Turnover Ratio
4.50%
Amplitude
22.03%
Avg Price
4.561
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
CEO: Mr. Antony C. Mattessich
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...